Skelding KA - Search Results

1

The Role of DNA Repair Pathways in AML Chemosensitivity.

Pearsall EA, Lincz LF, Skelding KA. Pearsall EA, et al. Among authors: skelding ka. Curr Drug Targets. 2018;19(10):1205-1219. doi: 10.2174/1389450119666180110093713. Curr Drug Targets. 2018. PMID: 29318968 Review.

2

Phosphorylation of calcium/calmodulin-stimulated protein kinase II at T286 enhances invasion and migration of human breast cancer cells.

Chi M, Evans H, Gilchrist J, Mayhew J, Hoffman A, Pearsall EA, Jankowski H, Brzozowski JS, Skelding KA. Chi M, et al. Among authors: skelding ka. Sci Rep. 2016 Sep 8;6:33132. doi: 10.1038/srep33132. Sci Rep. 2016. PMID: 27605043 Free PMC article.

3

A Novel Role for Brain and Acute Leukemia Cytoplasmic (BAALC) in Human Breast Cancer Metastasis.

Birgersson M, Chi M, Miller C, Brzozowski JS, Brown J, Schofield L, Taylor OG, Pearsall EA, Hewitt J, Gedye C, Lincz LF, Skelding KA. Birgersson M, et al. Among authors: skelding ka. Front Oncol. 2021 Apr 22;11:656120. doi: 10.3389/fonc.2021.656120. eCollection 2021. Front Oncol. 2021. PMID: 33968759 Free PMC article.

4

PARP Inhibitors and Haematological Malignancies-Friend or Foe?

Skelding KA, Lincz LF. Skelding KA, et al. Cancers (Basel). 2021 Oct 23;13(21):5328. doi: 10.3390/cancers13215328. Cancers (Basel). 2021. PMID: 34771492 Free PMC article. Review.

5

Targeting the two-pore channel 2 in cancer progression and metastasis.

Skelding KA, Barry DL, Theron DZ, Lincz LF. Skelding KA, et al. Explor Target Antitumor Ther. 2022;3(1):62-89. doi: 10.37349/etat.2022.00072. Epub 2022 Feb 28. Explor Target Antitumor Ther. 2022. PMID: 36046356 Free PMC article. Review.

6

Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia.

Skelding KA, Barry DL, Theron DZ, Lincz LF. Skelding KA, et al. Int J Mol Sci. 2022 Dec 29;24(1):563. doi: 10.3390/ijms24010563. Int J Mol Sci. 2022. PMID: 36614005 Free PMC article. Review.

7

High Expression of ENO1 and Low Levels of Circulating Anti-ENO1 Autoantibodies in Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukaemia.

Lincz LF, Theron DZ, Barry DL, Scorgie FE, Sillar J, Sefhore O, Enjeti AK, Skelding KA. Lincz LF, et al. Among authors: skelding ka. Cancers (Basel). 2024 Feb 22;16(5):884. doi: 10.3390/cancers16050884. Cancers (Basel). 2024. PMID: 38473245 Free PMC article.

8

Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors.

Smith AM, Dun MD, Lee EM, Harrison C, Kahl R, Flanagan H, Panicker N, Mashkani B, Don AS, Morris J, Toop H, Lock RB, Powell JA, Thomas D, Guthridge MA, Moore A, Ashman LK, Skelding KA, Enjeti A, Verrills NM. Smith AM, et al. Among authors: skelding ka. Oncotarget. 2016 Jul 26;7(30):47465-47478. doi: 10.18632/oncotarget.10167. Oncotarget. 2016. PMID: 27329844 Free PMC article.

9

The role of Ca²⁺-calmodulin stimulated protein kinase II in ischaemic stroke - A potential target for neuroprotective therapies.

Rostas JAP, Spratt NJ, Dickson PW, Skelding KA. Rostas JAP, et al. Among authors: skelding ka. Neurochem Int. 2017 Jul;107:33-42. doi: 10.1016/j.neuint.2017.01.012. Epub 2017 Jan 31. Neurochem Int. 2017. PMID: 28153786 Review.

10

Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets.

Taylor OG, Brzozowski JS, Skelding KA. Taylor OG, et al. Among authors: skelding ka. Front Oncol. 2019 Sep 26;9:963. doi: 10.3389/fonc.2019.00963. eCollection 2019. Front Oncol. 2019. PMID: 31616641 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page